Antimicrobial photodynamic therapy using a diode laser with a potential new photosensitizer, indocyanine green-loaded nanospheres, may be effective for the clearance of Porphyromonas gingivalis

Journal of Periodontal Research

Volumn 48, Issue 5, 2013, Pages 591-599

  Nagahara, A ^a   Mitani, A ^a   Fukuda, M ^a   Yamamoto, H ^a   Tahara, K ^a   Morita, I ^a   Ting, C C ^a,b   Watanabe, T ^a   Fujimura, T ^a   Osawa, K ^a   Sato, S ^a   Takahashi, S ^a   Iwamura, Y ^a   Kuroyanagi, T ^a   Kawashima, Y ^a   Noguchi, T ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Periodontal treatment; Photodynamic therapy; Photosensitizer; Porphyromonas gingivalis

Indexed keywords

ANTIINFECTIVE AGENT; CHITOSAN; INDOCYANINE GREEN; NANOSPHERE; PHOTOSENSITIZING AGENT;

ARTICLE; BACTERIAL LOAD; BACTERIUM ADHERENCE; CHEMISTRY; DIODE LASER; DRUG DELIVERY SYSTEM; DRUG EFFECT; FLUORESCENCE MICROSCOPY; HUMAN; METHODOLOGY; MICROBIAL VIABILITY; MICROBIOLOGY; PERIODONTAL DISEASE; PERIODONTAL TREATMENT; PHASE CONTRAST MICROSCOPY; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PORPHYROMONAS GINGIVALIS; RADIATION DOSE; SCANNING ELECTRON MICROSCOPY; TEMPERATURE;

PERIODONTAL TREATMENT; PHOTODYNAMIC THERAPY; PHOTOSENSITIZER; PORPHYROMONAS GINGIVALIS;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BACTERIAL LOAD; CHITOSAN; DRUG DELIVERY SYSTEMS; HUMANS; INDOCYANINE GREEN; LASERS, SEMICONDUCTOR; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; NANOSPHERES; PERIODONTAL DISEASES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYROMONAS GINGIVALIS; RADIATION DOSAGE; TEMPERATURE;

EID: 84883447070     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12042     Document Type: Article

References (48)

1. Chaves ES, Jeffcoat MK, Ryerson CC, Snyder B. Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy. J Clin Periodontol 2000;27:897-903.
2. Renvert S, Dahlen G, Wikstrom M. Treatment of periodontal disease based on microbiological diagnosis. Relation between microbiological and clinical parameters during 5 years. J Periodontol 1996;67:562-571.
3. Sbordone L, Ramaglia L, Gulletta E, Iacono V. Recolonization of the subgingival microflora after scaling and root planing in human periodontitis. J Periodontol 1990;61:579-584.
4. Fosse T, Madinier I, Hitzig C, Charbit Y. Prevalence of beta-lactamase-producing strains among 149 anaerobic gram-negative rods isolated from periodontal pockets. Oral Microbiol Immunol 1999;14:352-357.
5. Handal T, Olsen I, Walker CB, Caugant DA. Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis. Oral Microbiol Immunol 2004;19:303-308.
6. Lanker Klossner B, Widmer HR, Frey F. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine. Dermatology 1997;195(suppl 2):10-13.
7. Quirynen M, Teughels W, van Steenberghe D. Microbial shifts after subgingival debridement and formation of bacterial resistance when combined with local or systemic antimicrobials. Oral Dis 2003;9(suppl 1):30-37.
8. Radvar M, Pourtaghi N, Kinane DF. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets. J Periodontol 1996;67:860-865.
9. White DG, McDermott PF. Biocides, drug resistance and microbial evolution. Curr Opin Microbiol 2001;4:313-317.
10. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol, B 1997;39:1-18.
11. Pfitzner A, Sigusch BW, Albrecht V, Glockmann E. Killing of periodontopathogenic bacteria by photodynamic therapy. J Periodontol 2004;75:1343-1349.
12. Sawa M, Awazu K, Takahashi T et al. Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green. Br J Ophthalmol 2004;88:826-831.
13. Fox IJ, Wood EH. Indocyanine green: physical and physiologic properties. Proc Staff Meet Mayo Clin 1960;35:732-744.
14. Baumler W, Abels C, Karrer S et al. Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 1999;80:360-363.
15. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960;39:592-600.
16. Baker KJ. Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasma alpha-1 lipoproteins. Proc Soc Exp Biol Med 1966;122:957-963.
17. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961;21:43-57.
18. Damgé C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP. Nanocapsules as carriers for oral peptide delivery. J Controlled Release 1990;13:233-239.
19. Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol 2000;5:77-85.
20. Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 2001;47:55-64.
21. Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 2007;59:718-728.
22. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329-347.
23. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002;16:1217-1226.
24. Shenoy D, Little S, Langer R, Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Pharm Res 2005;22:2107-2114.
25. Devalapally H, Shenoy D, Little S, Langer R, Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Cancer Chemother Pharmacol 2007;59:477-484.
26. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev 1997;28:43-70.
27. Konan YN, Berton M, Gurny R, Allemann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci 2003;18:241-249.
28. Ricci-Junior E, Marchetti JM. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int J Pharm 2006;310:187-195.
29. Pagonis TC, Chen J, Fontana CR et al. Nanoparticle-based endodontic antimicrobial photodynamic therapy. J Endod 2010;36:322-328.
30. Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown ST. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J Photochem Photobiol, B 1996;32:159-164.
31. Soukos NS, Ximenez-Fyvie LA, Hamblin MR, Socransky SS, Hasan T. Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother 1998;42:2595-2601.
32. Merchat M, Bertolini G, Giacomini P, Villanueva A, Jori G. Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. J Photochem Photobiol, B 1996;32:153-157.
33. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
34. Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 2005;102:373-381.
35. Urbanska K, Romanowska-Dixon B, Matuszak Z, Oszajca J, Nowak-Sliwinska P, Stochel G. Indocyanine green as a prospective sensitizer for photodynamic therapy of melanomas. Acta Biochim Pol 2002;49:387-391.
36. Mochizuki-Oda N, Kataoka Y, Cui Y, Yamada H, Heya M, Awazu K. Effects of near-infra-red laser irradiation on adenosine triphosphate and adenosine diphosphate contents of rat brain tissue. Neurosci Lett 2002;323:207-210.
37. Theodoro LH, Haypek P, Bachmann L et al. Effect of ER:YAG and diode laser irradiation on the root surface: morphological and thermal analysis. J Periodontol 2003;74:838-843.
38. Kömerik N, Nakanishi H, MacRobert AJ, Henderson B, Speight P, Wilson M. In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model. Antimicrob Agents Chemother 2003;47:932-940.
39. de Oliveira RR, Schwartz-Filho HO, Novaes AB et al. Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: cytokine profile in gingival crevicular fluid, preliminary results. J Periodontol 2009;80:98-105.
40. Fernandes LA, de Almeida JM, Theodoro LH et al. Treatment of experimental periodontal disease by photodynamic therapy in immunosuppressed rats. J Clin Periodontol 2009;36:219-228.
41. Fontana CR, Abernethy AD, Som S et al. The antibacterial effect of photodynamic therapy in dental plaque-derived biofilms. J Periodontal Res 2009;44:751-759.
42. Kömerik N, Wilson M. Factors influencing the susceptibility of Gram-negative bacteria to toluidine blue O-mediated lethal photosensitization. J Appl Microbiol 2002;92:618-623.
43. Kömerik N, Wilson M, Poole S. The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol 2000;72:676-680.
44. Zanin IC, Lobo MM, Rodrigues LK, Pimenta LA, Hofling JF, Goncalves RB. Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur J Oral Sci 2006;114:64-69.
45. Zanin IC, Goncalves RB, Junior AB, Hope CK, Pratten J. Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother 2005;56:324-330.
46. Cuero RG. Antimicrobial action of exogenous chitosan. Exs 1999;87:315-333.
47. Fujiwara M, Hayashi Y, Ohara N. Inhibitory effect of water-soluble chitosan on growth of Streptococcus mutans. New Microbiol 2004;27:83-86.
48. Rabea EI, Badawy ME, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003;4:1457-1465.